Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes

被引:63
作者
Arany, I
Brysk, MM
Brysk, H
Tyring, SK
机构
[1] UNIV TEXAS,MED BRANCH,DEPT MICROBIOL & IMMUNOL,GALVESTON,TX 77555
[2] UNIV TEXAS,MED BRANCH,DEPT DERMATOL,GALVESTON,TX 77555
关键词
D O I
10.1006/bbrc.1996.0452
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inducible nitric oxide synthase (iNOS) transcription is regulated by cytokines and immune stimuli in various cell types. However, there are few data available on iNOS expression and regulation in keratinocytes, even though it can play a role in keratinocyte proliferation during inflammation following wound healing. Our studies demonstrated a differentiation-dependent regulation of iNOS transcription in human keratinocytes from epidermis but not in buccal mucosal cells, which are less differentiated. Different interferon (IFN) types (alpha and gamma) regulated skin keratinocyte iNOS mRNA levels in different ways, predominantly in a differentiation-dependent manner. TGF beta 1 and IFN alpha can antagonize IFN gamma related iNOS induction. However, the antagonistic effects of IFN alpha on IFN gamma differ from those of TGF beta 1. Our studies demonstrate: (a) the presence of iNOS mRNA in human keratinocytes; (b) inducibility of iNOS mRNA by different cytokines; and (c) antagonism between certain cytokines in induction of iNOS mRNA. Further studies are needed to determine biological and therapeutical relevance of our findings. (C) 1996 Academic Press, Inc.
引用
收藏
页码:618 / 622
页数:5
相关论文
共 21 条
[1]   INTERFERON TREATMENT ENHANCES THE EXPRESSION OF UNDERPHOSPHORYLATED (BIOLOGICALLY-ACTIVE) RETINOBLASTOMA PROTEIN IN HUMAN PAPILLOMA VIRUS-INFECTED CELLS THROUGH THE INHIBITORY TGF-BETA-1/IFN-BETA CYTOKINE PATHWAY [J].
ARANY, I ;
RADY, P ;
TYRING, SK .
ANTIVIRAL RESEARCH, 1994, 23 (02) :131-141
[2]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[3]  
BLANCO FJ, 1995, J IMMUNOL, V154, P4018
[4]  
Brysk Miriam M., 1995, Molecular and Cellular Differentiation, V3, P213
[5]   INTERFERON-GAMMA MODULATES TERMINAL DIFFERENTIATION AND THE EXPRESSION OF DESQUAMIN IN CULTURED KERATINOCYTES [J].
BRYSK, MM ;
BELL, T ;
HOIDA, C ;
TYRING, SK ;
RAJARAMAN, S .
EXPERIMENTAL CELL RESEARCH, 1991, 197 (02) :140-147
[6]   GENE-EXPRESSION OF MARKERS ASSOCIATED WITH PROLIFERATION AND DIFFERENTIATION IN HUMAN KERATINOCYTES CULTURED FROM EPIDERMIS AND FROM BUCCAL MUCOSA [J].
BRYSK, MM ;
ARANY, I ;
BRYSK, H ;
CHEN, SH ;
CALHOUN, KH ;
TYRING, SK .
ARCHIVES OF ORAL BIOLOGY, 1995, 40 (09) :855-862
[7]  
CHRESROWN SE, 1994, BIOCHEM BIOPH RES CO, V200, P126
[8]   EXOGENOUS AND ENDOGENOUS TYPE-I INTERFERONS INHIBIT INTERFERON-GAMMA-INDUCED NITRIC-OXIDE PRODUCTION AND NITRIC-OXIDE SYNTHASE EXPRESSION IN MURINE PERITONEAL-MACROPHAGES [J].
DEGUCHI, M ;
SAKUTA, H ;
UNO, K ;
INABA, K ;
MURAMATSU, S .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (11) :977-984
[9]  
FEHSEL K, 1995, J IMMUNOL, V155, P2858
[10]  
GIACOMINI P, 1988, ANTICANCER RES, V8, P1153